Revisiting the Cholinergic Hypothesis in Alzheimer's Disease: Emerging Evidence from Translational and Clinical Research
作者： M. R. Farlow , M.-M. Mesulam , A. Vergallo , Harald Hampel , Z. S. Khachaturian
关键词: Cholinesterase 、 Neuroscience 、 Neurodegeneration 、 Cerebral cortex 、 Disease 、 Cholinergic 、 Medicine 、 Neurology 、 Atrophy 、 Neuroimaging
摘要: Scientific evidence collected over the past 4 decades suggests that a loss of cholinergic innervation in the cerebral cortex of patients with Alzheimer's disease is an early pathogenic …
springer.com
jpreventionalzheimer.com
researchgate.net 参考文章(108)
P.Murali Doraiswamy, K.Ranga Rama Krishnan, Ravi Anand, Hyesung Sohn, Jacquiline Danyluk, Richard D. Hartman, Jeffrey Veach, Long-term effects of rivastigmine in moderately severe Alzheimer's disease: does early initiation of therapy offer sustained benefits? Progress in Neuro-psychopharmacology & Biological Psychiatry. ,vol. 26, pp. 705- 712 ,(2002) , 10.1016/S0278-5846(01)00326-8
Long-term donepezil treatment in 565 patients with Alzheimer's disease (AD2000): randomised double-blind trial. The Lancet. ,vol. 363, pp. 2105- 2115 ,(2004) , 10.1016/S0140-6736(04)16499-4
Ingo Kilimann, Michel Grothe, Helmut Heinsen, Eduardo Joaquim Lopez Alho, Lea Grinberg, Edson Amaro Jr, Gláucia Aparecida Bento Dos Santos, Rafael Emídio da Silva, Alex J Mitchell, Giovanni B Frisoni, Arun LW Bokde, Andreas Fellgiebel, Massimo Filippi, Harald Hampel, Stefan Klöppel, Stefan J Teipel, None, Subregional basal forebrain atrophy in Alzheimer's disease: a multicenter study. Journal of Alzheimer's Disease. ,vol. 40, pp. 687- 700 ,(2014) , 10.3233/JAD-132345
Sandrine Andrieu, Nicola Coley, Paul Aisen, Maria C. Carrillo, Steven DeKosky, Jane Durga, Howard Fillit, Giovanni B. Frisoni, Lutz Froelich, Serge Gauthier, Roy Jones, Linus Jönsson, Zaven Khachaturian, John C. Morris, Jean-Marc Orgogozo, Pierre-Jean Ousset, Philippe Robert, Eric Salmon, Cristina Sampaio, Frans Verhey, Gordon Wilcock, Bruno Vellas, Methodological issues in primary prevention trials for neurodegenerative dementia. Journal of Alzheimer's Disease. ,vol. 16, pp. 235- 270 ,(2009) , 10.3233/JAD-2009-0971
A. Claudio Cuello, Effects of trophic factors on the CNS cholinergic phenotype. Progress in Brain Research. ,vol. 109, pp. 347- 358 ,(1996) , 10.1016/S0079-6123(08)62117-2
Abraham Fisher, Cholinergic modulation of amyloid precursor protein processing with emphasis on M1 muscarinic receptor: perspectives and challenges in treatment of Alzheimer's disease. Journal of Neurochemistry. ,vol. 120, pp. 22- 33 ,(2012) , 10.1111/J.1471-4159.2011.07507.X
M.-Marsel Mesulam, Cholinergic Circuitry of the Human Nucleus Basalis and Its Fate in Alzheimer's Disease The Journal of Comparative Neurology. ,vol. 521, pp. 4124- 4144 ,(2013) , 10.1002/CNE.23415
Mark H. Tuszynski, Jennifer H. Yang, David Barba, Hoi-Sang U, Roy A. E. Bakay, Mary M. Pay, Eliezer Masliah, James M. Conner, Peter Kobalka, Subhojit Roy, Alan H. Nagahara, Nerve Growth Factor Gene Therapy: Activation of Neuronal Responses in Alzheimer Disease JAMA Neurology. ,vol. 72, pp. 1139- 1147 ,(2015) , 10.1001/JAMANEUROL.2015.1807
Maria C. Carrillo, Bruno Vellas, New and different approaches needed for the design and execution of Alzheimer's clinical trials Alzheimers & Dementia. ,vol. 9, pp. 436- 437 ,(2013) , 10.1016/J.JALZ.2013.03.008
Raymond T. Bartus, H.R. Johnson, Short-term memory in the rhesus monkey: Disruption from the anti-cholinergic scopolamine Pharmacology Biochemistry and Behavior. ,vol. 5, pp. 39- 46 ,(1976) , 10.1016/0091-3057(76)90286-0